To determine the potential relevance of DNAH8 and DNAH5 in human prostate cancer, we examined for differences in mRNA expression among normal, primary and metastatic samples from independent validation cohorts containing 235 normal prostate, 329 primary tumor and 59 metastatic tumor cases [16–18]. The gene discussed is DNAH8; the disease is neoplasm.